Skip to main content
Pharmacognosy Research logoLink to Pharmacognosy Research
letter
. 2011 Oct-Dec;3(4):273. doi: 10.4103/0974-8490.89749

A search for mosquito larvicidal compounds by blocking the sterol carrying protein, AeSCP-2, through computational screening and docking strategies

R Barani Kumar 1,✉
PMCID: PMC3249788  PMID: 22224052

Sir,

We would like to add a note that in our recent publication on “A search for mosquito larvicidal compounds by blocking the sterol carrying protein, AeSCP-2, through computational screening and docking strategies”[1] and reported the results based on in silico docking experiments that α-mangostin as a best inhibitor; however, Larson et al. 2010[2] performed assay-based screening and assessed the toxicity and dosage levels of -mangostin. Unfortunately, we missed citing this article which would be important to explain our results and this is not intentional. We greatly acknowledge Dr. Q. Lan for intimating us the same.

REFERENCES

  • 1.Kumar RB, Shanmugapriya B, Thiyagesan K, Kumar SR, Xavier SM. A search for mosquito larvicidal compounds by blocking the sterol carrying protein, AeSCP-2, through computational screening and docking strategies. Pharmacogn Res. 2010;2:247–53. doi: 10.4103/0974-8490.69126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Larson RT, Lorch JM, Pridgeon JW, Becnel JJ, Clark GG, Lan Q. The biological activity of alpha-mangostin, a larvicidal botanic mosquito sterol carrier protein-2 inhibitor. J Med Entomol. 2010;47:249–57. doi: 10.1603/me09160. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Pharmacognosy Research are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES